A novel radiosurgical platform to treat a case of uveal melanoma
Source: Modern Retina, April 2025
The ZAP-X system is described by researchers as a “dedicated, self-contained, and self-shielded surgical robot" designed for performing stereotactic surgery (SRS) on the brain, head, and neck. This technology was utilized to treat a patient with uveal melanoma.
A relatively new technology, The ZAP-X?system (Zap Surgical Systems Inc., San Carlos, CA), described by investigators as a “dedicated self-contained and self-shielded surgical robot for performing stereotactic surgery (SRS) of the brain, head, and neck,” was used to treat a patient with uveal melanoma.
The investigative team, led by Stephan Kinzl, MD, explained that “SRS is a recognized procedure for treating benign tumors including vestibular schwannoma, meningioma, pituitary adenoma, neuroma of other cranial nerves, and glomus-jugular tumors, and malignant tumors like brain metastasis, glioblastoma recurrence, and chondrosarcoma and for treating trigeminal neuralgia and arteriovenous malformations. Dr. Kinzl is from the Department of Ophthalmology, Stadtspital Zurich, Zurich. He and his colleagues reported their experience with the Zap-X system in Cureus.